المؤلفون: Dodonova SA; Research Institute of Experimental Medicine, Department of Pathophysiology, Kursk State Medical University, 305041 Kursk, Russia., Zhidkova EM; Department of Chemical Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia., Kryukov AA; Research Institute of Experimental Medicine, Department of Pathophysiology, Kursk State Medical University, 305041 Kursk, Russia., Valiev TT; Department of Chemical Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia., Kirsanov KI; Department of Chemical Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.; Faculty of Oncology, Ryazan State Medical University Named after Academician I.P. Pavlov, 390026 Ryazan, Russia., Kulikov EP; Laboratory of Single Cell Biology, Russian University of People's Friendship (RUDN) University, 117198 Moscow, Russia., Budunova IV; Department of Dermatology, Northwestern University, Chicago, IL 60611, USA., Yakubovskaya MG; Department of Chemical Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.; Faculty of Oncology, Ryazan State Medical University Named after Academician I.P. Pavlov, 390026 Ryazan, Russia., Lesovaya EA; Department of Chemical Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.; Faculty of Oncology, Ryazan State Medical University Named after Academician I.P. Pavlov, 390026 Ryazan, Russia.; Laboratory of Single Cell Biology, Russian University of People's Friendship (RUDN) University, 117198 Moscow, Russia.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 15; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Synephrine*/adverse effects , Citrus*/metabolism, Animals ; Receptors, Glucocorticoid/metabolism ; Plant Extracts/pharmacology ; Anti-Inflammatory Agents

المؤلفون: Gurieva OD; Department of Pediatric Oncology and Hematology Research Institute, N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia, Moscow, Russia., Savelyeva MI; Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia, Yaroslavl, Russia., Valiev TT; Department of Pediatric Oncology and Hematology Research Institute, N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia, Moscow, Russia.; Department of Oncology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia, Moscow, Russia., Sozaeva ZA; Research Institute of Molecular and Personalized Medicine, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Kondratenko SN; Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia, Moscow, Russia., Ilyin MV; Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia, Yaroslavl, Russia.

المصدر: Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2023 Dec 14; Vol. 38 (4), pp. 349-357. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: De Gruyter Country of Publication: Germany NLM ID: 101653409 Publication Model: eCollection Cited Medium: Internet ISSN: 2363-8915 (Electronic) Linking ISSN: 23638915 NLM ISO Abbreviation: Drug Metab Pers Ther Subsets: MEDLINE

مواضيع طبية MeSH: Methotrexate*/adverse effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Child ; Humans ; Polymorphism, Single Nucleotide ; Pharmacogenetics ; Risk Factors ; Genotype ; Liver-Specific Organic Anion Transporter 1/genetics

المؤلفون: Golubenko EO; Department of Obstetrics and Gynecology, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Savelyeva MI; Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia, Yaroslavl, Russia., Sozaeva ZA; Research Institute of Molecular and Personalized Medicine, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Korennaya VV; Department of Obstetrics and Gynecology, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Poddubnaya IV; Oncology Department, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Valiev TT; Department of Pediatric Oncology and Hematology Research Institute, Blokhin' National Medical Research Cancer Center of the Ministry of Health of Russia, Moscow, Russia., Kondratenko SN; Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov' First Moscow State Medical University of the Ministry of Health of Russia, Moscow, Russia., Ilyin MV; Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia, Yaroslavl, Russia.

المصدر: Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2023 Jul 20; Vol. 38 (4), pp. 339-347. Date of Electronic Publication: 2023 Jul 20 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: De Gruyter Country of Publication: Germany NLM ID: 101653409 Publication Model: eCollection Cited Medium: Internet ISSN: 2363-8915 (Electronic) Linking ISSN: 23638915 NLM ISO Abbreviation: Drug Metab Pers Ther Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Drug-Related Side Effects and Adverse Reactions*/genetics, Humans ; Female ; Cytochrome P-450 CYP2D6/genetics ; Cytochrome P-450 CYP3A/genetics ; Cytochrome P-450 CYP2C19/genetics ; Pharmacogenomic Testing ; Cytochrome P-450 CYP2C9/genetics ; Genotype ; Tamoxifen/adverse effects

المؤلفون: Sharapova SO; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Pashchenko OE; Immunology Department, Pirogov Russian National Research Medical University, Moscow, Russia., Bondarenko AV; Department of Pediatric Infectious Diseases and Pediatric Immunology, Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine., Vakhlyarskaya SS; Clinical Immunology and Rheumatology Department, Russian Children's Clinical Hospital of Pirogov Russian National Research Medical University, Moscow, Russia., Prokofjeva T; Pediatric Clinic, Children's Clinical University Hospital, Riga, Latvia., Fedorova AS; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Savchak I; Pediatric Department, West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine., Mareika Y; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Valiev TT; Chemotherapy Hemoblastoses Department, Pediatric Oncology and Hematology Research Institute of N.N. Blokhin National Cancer Research Center of the Ministry of Health of Russian Federation, Moscow, Russia., Popa A; Propedevtica of Childhood Diseases Faculty, Pirogov Russian National Research Medical University, Moscow, Russia., Tuzankina IA; Institute of Immunology and Physiology of the Branch of the Russian Academy of Sciences, Federal State Autonomous Educational Intuition of Higher Professional Education (Ural Federal University of a Name of the First President of Russia, B.N. Yeltsin), Yekaterinburg, Russia., Vlasova EV; Clinical Department, Regional Children's Clinical Hospital №1, Yekaterinburg, Russia., Sakovich IS; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Polyakova EA; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Rumiantseva NV; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus., Naumchik IV; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus., Kulyova SA; Pediatric Oncology Department, N.N. Petrov National Medical Research Center of Oncology, St-Petersburg, Russia., Aleshkevich SN; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Golovataya EI; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus., Minakovskaya NV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Belevtsev MV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Latysheva EA; Immunopathology Department, NRC Institute of Immunology FMBA, Moscow, Russia., Latysheva TV; Immunopathology Department, NRC Institute of Immunology FMBA, Moscow, Russia., Beznoshchenko AG; Department of Pediatric Oncology/Hematology, Regional Children's Hospital, Ryazan, Russia., Akopyan H; Institute of Hereditary Pathology of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine., Makukh H; Institute of Hereditary Pathology of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine., Kozlova O; West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine., Varabyou DS; Department of Ecologic Geography, Belarusian State University, Minsk, Belarus., Ballow M; Department of Pediatrics, University of South Florida at Johns Hopkins All Children's Hospital, Saint Petersburg, FL, United States., Ong MS; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care, Boston, MA, United States., Walter JE; Department Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, Saint Petersburg, FL, United States., Kondratenko IV; Clinical Immunology and Rheumatology Department, Russian Children's Clinical Hospital of Pirogov Russian National Research Medical University, Moscow, Russia., Kostyuchenko LV; Pediatric Department, West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine., Aleinikova OV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.

المصدر: Frontiers in immunology [Front Immunol] 2021 Jan 08; Vol. 11, pp. 602482. Date of Electronic Publication: 2021 Jan 08 (Print Publication: 2020).

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Cell Cycle Proteins*/genetics , Cell Cycle Proteins*/immunology , Founder Effect* , Hematologic Neoplasms*/genetics , Hematologic Neoplasms*/immunology , Hematologic Neoplasms*/mortality , Lymphoproliferative Disorders*/genetics , Lymphoproliferative Disorders*/immunology , Lymphoproliferative Disorders*/mortality , Nijmegen Breakage Syndrome*/genetics , Nijmegen Breakage Syndrome*/immunology , Nijmegen Breakage Syndrome*/mortality , Nuclear Proteins*/genetics , Nuclear Proteins*/immunology, Adolescent ; Adult ; Child ; Child, Preschool ; Europe, Eastern/epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Prevalence ; Quality of Life ; Retrospective Studies

المؤلفون: Baryakh EA; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Tyurina NG; P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow, Russia., Vorobyev VI; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Gemdzhyan EG; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Mangasarova YK; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Klyasova GA; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Kovrigina AM; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Obukhova TN; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Zvonkov EE; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Vernyuk MA; P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow, Russia., Chervontseva AM; P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow, Russia., Polyakov YY; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Misyurina АЕ; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Valiev TT; Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Zherebtsova VA; Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation, Moscow, Russia., Magomedova AU; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Galstyan GM; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Yatskov KV; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Nesterova ES; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Vorobyev AI; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Kravchenko SK; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia.

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (7), pp. 4-14.

نوع المنشور: Editorial; English Abstract

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Forecasting*, Antineoplastic Agents/*therapeutic use , Burkitt Lymphoma/*drug therapy, Adolescent ; Adult ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Young Adult

المؤلفون: Vinogradova IuE, Lutsenko IN, Kaplanskaia IB, Vorob'ev IA, Samoĭlova RS, Gorgidze LA, Ryzhikova NA, Valiev TT, Giliazitdinova EA, Dzhulakian UL, Egorova EK, Zvonkov EE, Krasil'nikova BB, Magomedova AU, Margolin OV, Mar'in DS, Kremenetskaia AM, Kravchenko SK, Vorob'ev AI

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2008; Vol. 80 (7), pp. 33-7.

نوع المنشور: Comparative Study; English Abstract; Journal Article

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lymphoma, Large-Cell, Anaplastic/*drug therapy, Adolescent ; Adult ; Asparaginase/therapeutic use ; Bleomycin/therapeutic use ; Cyclophosphamide/therapeutic use ; Daunorubicin/therapeutic use ; Dose-Response Relationship, Drug ; Doxorubicin/therapeutic use ; Etoposide/therapeutic use ; Female ; Follow-Up Studies ; Humans ; Leucovorin/therapeutic use ; Lymphoma, Large-Cell, Anaplastic/diagnosis ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Prednisone/therapeutic use ; Procarbazine/therapeutic use ; Remission Induction/methods ; Treatment Outcome ; Vincristine/therapeutic use

SCR Protocol: BEACOPP protocol; CHOP protocol; MACOP-B protocol; PVDA protocol

المؤلفون: Valiev TT, Vinogradova IuE, Chernova NG, Mar'in DS, Volkova IaK, Petrova VI, Bulanov AIu, Kalinin NN, Semenova EA, Gretsov EM, Kravchenko SK, Kremenetskaia AM, Vorob'ev AI

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2006; Vol. 78 (7), pp. 87-90.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Leukemia, Prolymphocytic/*drug therapy , Leukemia, T-Cell/*drug therapy, Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/therapeutic use ; Humans ; Leukemia, Prolymphocytic/diagnosis ; Leukemia, T-Cell/diagnosis ; Male ; Middle Aged ; Mitoxantrone/administration & dosage ; Mitoxantrone/therapeutic use ; Remission Induction ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives ; Vidarabine/therapeutic use